Brown S, Tadros A, Montagna G, Bell T, Crowley F, Gallagher E
Front Pharmacol. 2024; 15:1457363.
PMID: 39318780
PMC: 11420520.
DOI: 10.3389/fphar.2024.1457363.
Noguchi M, Inokuchi M, Yokoi-Noguchi M, Morioka E, Haba Y
Cancers (Basel). 2023; 15(22).
PMID: 38001613
PMC: 10670757.
DOI: 10.3390/cancers15225353.
Benolken M, Jakub J
Ann Surg Oncol. 2023; 30(10):6051-6052.
PMID: 37477746
DOI: 10.1245/s10434-023-13959-6.
Benolken M, McLaughlin S, Piltin M, Mrdutt M, Li Z, Jakub J
Ann Surg Oncol. 2023; 30(10):6042-6049.
PMID: 37466868
DOI: 10.1245/s10434-023-13883-9.
Sun S, Bai J, Wang X
Front Surg. 2023; 10:1180919.
PMID: 37255743
PMC: 10225584.
DOI: 10.3389/fsurg.2023.1180919.
The prevention and treatment of breast cancer- related lymphedema: A review.
McEvoy M, Gomberawalla A, Smith M, Boccardo F, Holmes D, Djohan R
Front Oncol. 2022; 12:1062472.
PMID: 36561522
PMC: 9763870.
DOI: 10.3389/fonc.2022.1062472.
Evaluation of Relative Abundance of Lymphedema after Reverse Axillary Mapping in Patients with Breast Cancer.
Eshraghi Samani R, Ebrahimi H, Rafiee Zadeh A, Safaee M
Adv Biomed Res. 2022; 11:36.
PMID: 35720216
PMC: 9201235.
DOI: 10.4103/abr.abr_281_21.
Utility of Axillary Reverse Mapping (ARM) and Incidence of Metastasis in Arm Draining Lymph Nodes in Patients with Breast Cancer.
Kumar P, Singh P, Veerwal H, Ravi B, Narayan M
World J Nucl Med. 2022; 21(1):28-33.
PMID: 35502281
PMC: 9056132.
DOI: 10.1055/s-0042-1744198.
Axillary Reverse Mapping in Patients Undergoing Axillary Lymph Node Dissection: A Single Institution Experience From India.
Jena S, Bhattacharya S, Gupta A, Sinha N
Cureus. 2021; 13(7):e16462.
PMID: 34422491
PMC: 8370656.
DOI: 10.7759/cureus.16462.
Clinical application of axillary reverse mapping in patients with breast cancer: A systematic review and meta-analysis.
Wijaya W, Peng J, He Y, Chen J, Cen Y
Breast. 2020; 53:189-200.
PMID: 32858404
PMC: 7474002.
DOI: 10.1016/j.breast.2020.08.007.
Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.
Liu S, Wang N, Gao P, Liu P, Yang H, Xie F
World J Surg Oncol. 2020; 18(1):118.
PMID: 32482174
PMC: 7265626.
DOI: 10.1186/s12957-020-01886-9.
Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments.
Gillespie T, Sayegh H, Brunelle C, Daniell K, Taghian A
Gland Surg. 2018; 7(4):379-403.
PMID: 30175055
PMC: 6107585.
DOI: 10.21037/gs.2017.11.04.
Feasibility of Axillary Reverse Mapping and Clinicopathological Features Predicting ARM Node Metastasis in Breast Cancer-a Pilot Study.
Shiva Kumar K, Hemanth G, Panjwani P, Manjunath S, Ramesh R, Burrah R
Indian J Surg Oncol. 2017; 8(2):119-122.
PMID: 28546704
PMC: 5427024.
DOI: 10.1007/s13193-016-0578-1.
The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies.
Han C, Yang B, Zuo W, Zheng G, Yang L, Zheng M
PLoS One. 2016; 11(2):e0150285.
PMID: 26919589
PMC: 4769133.
DOI: 10.1371/journal.pone.0150285.
Axillary reverse mapping: five-year experience.
Ochoa D, Korourian S, Boneti C, Adkins L, Badgwell B, Klimberg V
Surgery. 2014; 156(5):1261-8.
PMID: 25444319
PMC: 4354953.
DOI: 10.1016/j.surg.2014.05.011.
Recent progress in the treatment and prevention of cancer-related lymphedema.
Shaitelman S, Cromwell K, Rasmussen J, Stout N, Armer J, Lasinski B
CA Cancer J Clin. 2014; 65(1):55-81.
PMID: 25410402
PMC: 4808814.
DOI: 10.3322/caac.21253.
Nodal status assessment in breast cancer: strategies of clinical grounds and quality of life implications.
Orsaria P, Varvaras D, Vanni G, Pagnani G, Scaggiante J, Frusone F
Int J Breast Cancer. 2014; 2014:469803.
PMID: 24672730
PMC: 3942203.
DOI: 10.1155/2014/469803.
Prospective study evaluating oncological safety of axillary reverse mapping.
Schunemann Jr E, Doria M, Silvestre J, Gasperin Jr P, Cavalcanti T, Budel V
Ann Surg Oncol. 2014; 21(7):2197-202.
PMID: 24599413
PMC: 4047480.
DOI: 10.1245/s10434-014-3626-5.
Toward nodal staging of axillary lymph node basins through intradermal administration of fluorescent imaging agents.
Meric-Bernstam F, Rasmussen J, Krishnamurthy S, Tan I, Zhu B, Wagner J
Biomed Opt Express. 2014; 5(1):183-96.
PMID: 24466486
PMC: 3891331.
DOI: 10.1364/BOE.5.000183.
Axillary reverse mapping using fluorescence imaging is useful for identifying the risk group of postoperative lymphedema in breast cancer patients undergoing sentinel node biopsies.
Sakurai T, Endo M, Shimizu K, Yoshimizu N, Nakajima K, Nosaka K
J Surg Oncol. 2013; 109(6):612-5.
PMID: 24310418
PMC: 4263257.
DOI: 10.1002/jso.23528.